Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.

Palle, Juliette

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study. [electronic resource] - Oncotarget Nov 2017 - 101383-101393 p. digital

Publication Type: Journal Article

1949-2553

10.18632/oncotarget.20711 doi